2023Organic Process Research & DevelopmentRequires access

Approaches and Considerations for the Investigation and Synthesis of N -Nitrosamine Drug Substance-Related Impurities (NDSRIs)

Ian W. Ashworth, Alexander Blanazs, Jonathan J. Byrne, Olivier Dirat, Jared W. Fennell, Nadine Kuhl, Stuart L. Wells, Matthew Whiting

Open publisher page 42 citations

Abstract

N -Nitrosamine risk assessment of pharmaceuticals has moved from an initial focus on the potential presence of known small-molecule N -nitrosamines such as N -nitrosodimethylamine (NDMA) and N -nitrosodiethylamine (NDEA) in active substances toward the potential for generation of more complex nitrosamine drug substance-related impurities (NDSRIs) in drug products. While N -nitrosation of simple secondary amines is well-understood, more complex amines can undergo alternative reaction pathways that can be more challenging to predict. A number of such complex amines are known not to undergo N -nitrosation but are either unreactive or react by alternative pathways such as C -nitrosation or nitration to generate non- N -nitrosamine products. This article proposes a standard set of three orthogonal nitrosation forced degradation type reaction conditions that can be used to investigate the potential for generation of novel N -nitrosamines by nitrosation of complex amines. These complementary reaction conditions are considered to provide a thorough evaluation of the potential for N -nitrosamine formation from complex amines with respect to risk factors within pharmaceutical manufacturing. If, after investigation of nitrosation under the proposed conditions, formation and isolation of an N -nitrosamine is not possible, the resultant understanding of chemical reactivity and stability can be used to justify that the N -nitrosamine in question would not be expected to be generated from the complex amine in the drug substance or product. If an N -nitrosamine is formed under these reaction conditions, the information gained can be used as part of the risk assessment and also provides a starting point for the development of a process to synthesize a discrete sample for further testing. Additionally, synthetic and analytical considerations that should be taken into account during preparation of novel N -nitrosamines for use in analytical or toxicological studies are discussed.

About this research paper

What this paper is about

N -Nitrosamine risk assessment of pharmaceuticals has moved from an initial focus on the potential presence of known small-molecule N -nitrosamines such as N -nitrosodimethylamine (NDMA) and N -nitrosodiethylamine (NDEA) in active substances toward the potential for generation of more complex nitrosamine drug substance-related impurities (NDSRIs) in drug products. While N -nitrosation of simple secondary amines is well-understood, more complex amines can undergo alternative reaction pathways that can be more challenging to predict. A number of such complex amines are known not to undergo N -nitrosation but are either unreactive or react by alternative pathways such as C -nitrosation or nitration to generate non- N -nitrosamine products. This article proposes a standard set of three orthogonal nitrosation forced degradation type reaction conditions that can be used to investigate the potential for generation of novel N -nitrosamines by nitrosation of complex amines. These complementary reaction conditions are considered to provide a thorough evaluation of the potential for N -nitrosamine formation from complex amines with respect to risk factors within pharmaceutical manufacturing. If, after investigation of nitrosation under the proposed conditions, formation and isolation of an N -nitrosamine is not possible, the resultant understanding of chemical reactivity and stability can be used to justify that the N -nitrosamine in question would not be expected to be generated from the complex amine in the drug substance or product. If an N -nitrosamine is formed under these reaction conditions, the information gained can be used as part of the risk assessment and also provides a starting point for the development of a process to synthesize a discrete sample for further testing. Additionally, synthetic and analytical considerations that should be taken into account during preparation of novel N -nitrosamines for use in analytical or toxicological studies are discussed.

Why it matters

OpenAlex reports 42 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

N -Nitrosamine risk assessment of pharmaceuticals has moved from an initial focus on the potential presence of known small-molecule N -nitrosamines such as N -nitrosodimethylamine (NDMA) and N -nitrosodiethylamine (NDEA) in active substances toward the potential for generation of more complex nitrosamine drug substance-related impurities (NDSRIs) in drug products. While N -nitrosation of simple secondary amines is well-understood, more complex amines can undergo alternative reaction pathways that can be more challenging to predict. A number of such complex amines are known not to undergo N -nitrosation but are either unreactive or react by alternative pathways such as C -nitrosation or nitration to generate non- N -nitrosamine products. This article proposes a standard set of three orthogonal nitrosation forced degradation type reaction conditions that can be used to investigate the potential for generation of novel N -nitrosamines by nitrosation of complex amines. These complementary reaction conditions are considered to provide a thorough evaluation of the potential for N -nitrosamine formation from complex amines with respect to risk factors within pharmaceutical manufacturing. If, after investigation of nitrosation under the proposed conditions, formation and isolation of an N -nitrosamine is not possible, the resultant understanding of chemical reactivity and stability can be used to justify that the N -nitrosamine in question would not be expected to be generated from the complex amine in the drug substance or product. If an N -nitrosamine is formed under these reaction conditions, the information gained can be used as part of the risk assessment and also provides a starting point for the development of a process to synthesize a discrete sample for further testing. Additionally, synthetic and analytical considerations that should be taken into account during preparation of novel N -nitrosamines for use in analytical or toxicological studies are discussed.

Key concepts: Nitrosamine, Nitrosation, Chemistry, Amine gas treating, Nitration, Organic chemistry, Reactivity (psychology), Combinatorial chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Approaches and Considerations for the Investigation and Synthesis of N -Nitrosamine Drug Substance-Related Impurities (NDSRIs) — Research Paper | ScholarLens